Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy
Top Cited Papers
Open Access
- 1 January 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (1), 130-139
- https://doi.org/10.1086/317541
Abstract
We evaluated metabolic and clinical features of 71 HIV-infected patients with lipodystrophy by comparing them with 213 healthy control subjects, matched for age and body mass index, from the Framingham Offspring Study. Thirty HIV-infected patients without fat redistribution were compared separately with 90 matched control subjects from the Framingham Offspring Study. Fasting glucose, insulin, and lipid levels; glucose and insulin response to standard oral glucose challenge; and anthropometric measurements were determined. HIV-infected patients with lipodystrophy demonstrated significantly increased waist-to-hip ratios, fasting insulin levels, and diastolic blood pressure compared with controls. Patients with lipodystrophy were more likely to have impaired glucose tolerance, diabetes, hypertriglyceridemia, and reduced levels of high-density lipoprotein (HDL) cholesterol than were controls. With the exception of HDL cholesterol level, these risk factors for cardiovascular disease (CVD) were markedly attenuated in patients without lipodystrophy and were not significantly different in comparison with controls. These data demonstrate a metabolic syndrome characterized by profound insulin resistance and hyperlipidemia. CVD risk factors are markedly elevated in HIV-infected patients with fat redistribution.Keywords
This publication has 35 references indexed in Scilit:
- The Mechanism of Insulin Resistance Caused by HIV Protease Inhibitor TherapyPublished by Elsevier BV ,2000
- Fasting Hyperinsulinemia in Human Immunodeficiency Virus-Infected Men: Relationship to Body Composition, Gonadal Function, and Protease Inhibitor UseJournal of Clinical Endocrinology & Metabolism, 2000
- Ability of Alternative Indices of Insulin Sensitivity to Predict Cardiovascular Risk: Comparison with the “Minimal Model”Annals of Epidemiology, 1998
- Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistanceThe Lancet, 1998
- Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudineAIDS, 1998
- Separate Associations Between Visceral and Subcutaneous Adipose Tissue Distribution, Insulin and Glucose Levels in Obese WomenDiabetes Care, 1996
- Increased de novo hepatic lipogenesis in human immunodeficiency virus infectionJournal of Clinical Endocrinology & Metabolism, 1993
- Glucose tolerance and the risk of cardiovascular diseases: The zutphen studyJournal of Clinical Epidemiology, 1992
- Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndromeJournal of Clinical Endocrinology & Metabolism, 1992
- Blood pressure as a risk factor for cardiovascular disease. The Framingham Study--30 years of follow-up.Hypertension, 1989